CFO
EMN icon

Callan Family Office’s Eastman Chemical EMN Stock Holding History

Callan Family Office’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,570
Closed -$225K – 1118
2025
Q3 		$225K Sell
3,570
-130
-4% -$9.07K 0.01% 794
2025
Q2 		$276K Buy
3,700
+1,343
+57% +$106K 0.01% 799
2025
Q1 		$208K Sell
2,357
-140
-6% -$13.2K 0.02% 520
2024
Q4 		$228K Buy
+2,497
New +$256K 0.01% 573

Other funds holding EMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Callan Family Office's EMN Position: Q4 2025 in Review

Callan Family Office sold out of Eastman Chemical (EMN) in Q4 2025, closing a stake of 3,570 shares — an estimated $225K sold.

Callan Family Office first reported a position in EMN in Q4 2024 and held it in 4 quarters. The position peaked at $276K in Q2 2025. 633 funds tracked by Wall St. Rank hold EMN as of Q4 2025.

  • Callan Family Office reported no remaining Eastman Chemical position as of Q4 2025 after selling out during the quarter.
  • Callan Family Office sold 3,570 Eastman Chemical shares in Q4 2025, an estimated $225K.
  • Callan Family Office first reported a position in Eastman Chemical in Q4 2024 and held it in 4 quarters.
  • Callan Family Office's Eastman Chemical position peaked at $276K in Q2 2025.
  • 633 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2025.

Based on Callan Family Office's 13F filing for Q4 2025, filed 12 Feb 2026.